Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Esmya (ulipristal acetate) - Important Safety Information from Gedeon Richter Plc. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
20/02/2018
Problem Or Issue:
Important Safety Information communication from Gedeon Richter Plc. on restrictions on the use of ulipristal acetate, Esmya 5 mg tablet, and important new warnings of serious liver injury and recommendations for liver monitoring.
Important Safety Information - Esmya (ulipristal acetate)
« Back
Date Printed: 28/03/2024